Compare Danaher Corporation (DHR) vs International Business Machines Corp (IBM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs International Business Machines Corp — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while International Business Machines Corp trades at $227.13 (market cap $213.50B). The key difference: International Business Machines Corp is the larger of the two by market cap, and International Business Machines Corp pays the higher dividend (2.98%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and International Business Machines Corp for 88 Days on average.
| DHR | IBM | |
|---|---|---|
Market Cap | $152.87B | $213.50B |
Volume | 5,228,698 | 8,908,687 |
Sector | Health | Technology |
52-Week High | $242.05 | $329.23 |
52-Week Low | $161.91 | $205.77 |
Typical Hold Time | 69 Days | 88 Days |
Enterprise Value | $175.08B | $270.64B |
Dividend Yield | 0.74% | 2.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
IBM's stock trades at $226.61, up 2.77% today, with a bearish technical signal but strong fundamentals including a 15.52% net income margin and consistent earnings beats. Recent news highlights the launch of self-hosted deployment for its Bob AI platform, boosting AI consulting prospects. Revenue grew to $67.54B in 2025, though cash flow turned negative due to heavy investing.
Outlook is mixed: analyst consensus targets $255.50 with 47% buy ratings, but technical weakness and a high P/E of 20.13 suggest caution. Risks include cyclical demand swings and debt levels, while AI initiatives offer growth potential. Investors should weigh solid profitability against near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →
